Variant #0000631826 (NC_000011.9:g.57365567G>T, NC_000011.9(NM_000062.2):c.-22-155G>T (SERPING1))
| Individual ID |
00275941 |
| Chromosome |
11 |
| Allele |
Unknown |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Affects function |
| Classification method |
ACMG |
| Clinical classification |
pathogenic |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.57365567G>T |
| DNA change (hg38) |
g.57598094G>T |
| Published as |
- |
| ISCN |
- |
| DB-ID |
SERPING1_000786 |
| Variant remarks |
The c.-22-155G>T variant introduces in the genome a new donor site stronger than the wild type leading to a larger exon 1 in the RNA level. The c.-22-155G>T variant disrupts an ISS recognized by a number of transcriptional factors and subsequently stops the suppression of the intronic cryptic donor site. Transcriptional analysis indicated that the mutant mRNA is susceptible to degradation. The c.-22-155G > T variant co-segregated with C1-INH-HAE in all of the 4 analyzed patients, while it was absent from 3 healthy family members. The c.-22-155G > T variant meets ACMG criteria to be considered pathogenic: PS3, PS4, PM2, PP1_Str, PP3, PP4 |
| Reference |
Journal: Vatsiou 2020 |
| ClinVar ID |
ClinVar-000870444 |
| dbSNP ID |
rs1945307391 |
| Origin |
Germline |
| Segregation |
yes |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
Retrieve |
| Owner |
Christian Drouet |
| Database submission license |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
| Created by |
Christian Drouet |
| Date created |
2020-01-21 15:04:53 +01:00 (CET) |
| Date last edited |
2024-11-30 20:09:46 +01:00 (CET) |

Variant on transcripts
Screenings
|